Publication
Title
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period
Author
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT Several noncardiovascular drugs with QT liability are currently on the market. Previous epidemiological studies have shown significant exposure of the general population to drugs with QT liability with similar consumption in many European countries. Several regulatory measures have concerned medicinal products carrying a pro-arrhythmic risk in humans. WHAT THIS STUDY ADDS The list of antibacterial agents with documented QT liability has grown over the last few years. Notwithstanding stringent regulatory measures, population exposure to antibiotics with QT liability is still significant in several countries. The magnitude of the problem is clearly heterogeneous, with remarkable diversity between Northern and Southern countries (lower and higher exposure, respectively).
Language
English
Source (journal)
British journal of clinical pharmacology. - London
Publication
London : 2008
ISSN
0306-5251
Volume/pages
67:1(2008), p. 88-98
ISI
000263303000012
Full text (Publishers DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 13.01.2009
Last edited 16.05.2017
To cite this reference